07 Sep, 2017 2017 Summer RNAi Roundtable Series
We hosted a series of online “RNAi Roundtables” in August and September, at which Alnylam scientists, clinical collaborators, and patients or patient advocates reviewed recent progress in many of the company’s late-stage pipeline programs and discussed the related disease areas.
Click on any of the RNAi Roundtables below to listen to the webcasts and view presentations from these events.
Patisiran, in development for the treatment of hereditary ATTR amyloidosis
Thursday, August 3, 10:30 am ET
Revusiran investigation results
Wednesday, August 9, 12:30 pm ET
Platform advances in RNAi therapeutics
Wednesday, August 23, 3:30 pm ET
Givosiran, in development for the treatment of acute hepatic porphyrias
Thursday, September 7, 10:30 am ET